Bromopride

ALIMENTARY TRACT AND METABOLISM

Key facts

Bromopride is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1976. DrugCentral lists 2 molecular targets, including DRD2 and ACHE.

• Molecular targets: DRD2 and ACHE (2 listed in DrugCentral).
• ATC code: A03FA04 (Propulsives).
• Molecular formula: C14H22BrN3O2; molecular weight 344.25 g/mol.

Mechanism & targets

Molecular targets (2)

Target	Gene	Action	Activity
D(2) dopamine receptor	DRD2	unknown	Ki 7.85
Acetylcholinesterase	ACHE	unknown	IC50 4.17

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
1976-01-01	YEAR INTRODUCED	—	—

ATC classification

ATC code	Therapeutic hierarchy
A03FA04	ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › PROPULSIVES › Propulsives

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Febrile neutropenia	35.6

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Bromopride is on its molecule page.

• Molecular formula: C₁₄H₂₂BrN₃O₂
• Molecular weight: 344.25 g/mol
• CAS number: 4093-35-0
• InChIKey: GIYAQDDTCWHPPL-UHFFFAOYSA-N
• PubChem CID: 2446

CCN(CC)CCNC(=O)C1=C(OC)C=C(N)C(Br)=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Bromopride work?

Its molecular targets in DrugCentral include DRD2 and ACHE.

When was Bromopride first approved?

Bromopride was first approved by the YEAR INTRODUCED in 1976.

What is the chemical formula of Bromopride?

Bromopride has the molecular formula C14H22BrN3O2 and a molecular weight of 344.25 g/mol.

Sources

• DrugCentral drug card 406 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL399510 — compound record and bioactivity
• PubChem CID 2446 — chemical identifiers
• DrugBank DB09018 — drug record
• FDA UNII 75473V2YZK — substance identity
• UniProt P14416 (DRD2) — target protein
• UniProt P22303 (ACHE) — target protein
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.